%0 Journal Article %A Mohammed Shanshal %A Hayder Saad Ahmed %T COVID-19 and Herpes Simplex Virus Infection: A Cross-Sectional Study %D 2021 %R 10.1101/2021.07.09.21260217 %J medRxiv %P 2021.07.09.21260217 %X Background Despite being variable and poorly characterized, the reported cutaneous manifestations of COVID-19 are of increasing concern.Aim of the Study This study aimed to assess the prevalence and possible association between COVID-19 and herpes simplex virus (HSV) infection.Patients and methods A 9-item questionnaire was sent to 120 PCR-confirmed COVID-19 patients with a response rate of 66.67%. This cross-sectional observational study included 80 patients with mild to moderate COVID-19 infection who did not require hospitalization or steroid therapy.Results One or more HSV infections were observed in 28 patients (35%) with COVID-19 infection, including 10 males (35.7%) and 18 females (64.29%). Of the 28 patients, fever was reported in 17 patients (75%) during COVID-19. Most of the respondents (78%) described a single HSV reactivation, 14.29% had 2 attacks, and 7.14% experienced 3 attacks. Compared to previous non-COVID-19 related HSV reactivation, the COVID-19 related attacks were more severe in 12 patients (42.85%), equally severe in 5 patients (17.85%) and less severe in 1 patient (3.57%). Interestingly, 10 patients (35.71%) developed an initial symptomatic HSV attack during COVID-19 infection.Conclusions This study demonstrated a possible association between COVID-19 infection and primary HSV infection and/or reactivation. The COVID-19 direct neuronal effect in addition to COVID-19 related psychological stress, fever and immunological dysregulation could play a potential role.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AFunding StatementFunding sources: NoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval: Arab Board of Health Specialization, MOH IraqAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A %U https://www.medrxiv.org/content/medrxiv/early/2021/07/12/2021.07.09.21260217.full.pdf